Page 3 - Vaccine

EU buys additional vaccine doses against monkeypox despite declining cases

The European Commission said it had secured over 10,000 tecovirimat vaccines against monkeypox, despite the declining number of cases in the European Union (EU)

What is Khosta-2? A vaccine-restraint virus found in Russian bats

It is classified as a sarbecovirus, a member of the Coronavirus family. It attaches to the same protein, ACE2 that Coronavirus uses to penetrate into human cells

India's Covid vaccination programme stunning: Roche's Hoffmann, Duschmale

'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'

ICAR signs tech transfer pact with Biovet for lumpy skin disease vaccine

India will need around 18-20 crore the indigenous lumpy vaccine doses to completely cover all the cattle population which is estimated to be around 193 million in a year

Nasal vaccines for Covid-19: How do they work and what are their benefits?

The Drugs Controller General of India (DCGI), on Tuesday, approved Bharat Biotech's anti-covid vaccine for emergency use. It is the first such vaccine in the country

US added to WHO countries with circulating vaccine-derived poliovirus list

The US now joins a list of nearly 30 other countries with circulating vaccine-derived poliovirus (cVDPV) identified by the WHO, the US Centers for Disease Control and Prevention (CDC) said

Soon, India to get an adult TB vaccine

Centre, states working jointly to stop spread of Lumpy Skin Disease: PM

Says indigenous vaccine and movement of animals being stopped to control the spread of LSD

Top Headlines: Gyanvapi verdict today, Russia's discounted oil, and more

In a bid to counter the growing clamour among the G7 nations to enforce a price cap on Russian oil, Moscow told New Delhi it is willing to provide petroleum at even lower rates than before to India

Bharat Biotech awaits booster dose nod for intranasal vaccine iNCOVACC

Bharat Biotech did not comment on its plans to make this vaccine available for young children

Fight against Covid-19: Here is a list of vaccines approved in India

Besides Bharat Biotech's nasal vaccine, India has 13 vaccines to fight against Covid-19. Two have been approved for manufacturing, while 11 have been approved for emergency use

National Immunisation Mission: How indigenous vaccines can go a long way

The locally developed Ceravac can play a critical role in the efficacy of the National Immunisation Mission

US holds 80% of global vaccine supply with 35% of monkeypox cases: Report

The analysis compared vaccine access and monkeypox cases in more than a dozen countries.

India-made cervical cancer vaccine Ceravac to cost Rs 200-400 per dose

Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices

SEC recommends Biological E's vaccine against S pneumonia for infants

Biological E Limited on Thursday announced that the Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO) reviewed and approved the Phase 3 infants' clinical trial data and recommended for manufacture its 14-valent paediatric vaccine (investigational pneumococcal polysaccharide conjugate vaccine PCV14) against S pneumonia infection, in single-dose and multi-dose presentations. A press release from the city-based vaccine maker said the PCV14 can be administered to infants at six, 10 and 14 weeks of age. Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries. With the PCV14 vaccine, BE hopes to contribute to the prevention of invasive pneumococcal disease and protect millions of lives globally. The safety analysis of the vaccine revealed that all the adverse events were mild to moderate in their intensity and with no grade-3 & 4 events reported. Mahima Datla, Managing ..

South Africa's Aspen, India's Serum Institute sign vaccines deal for Africa

South Africa's Aspen Pharmacare has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa

Covishield usage highest as precaution dose for Covid, says report

The usage of Covishield has been the highest as the precaution dose for COVID-19 as compared to other vaccines, said Union Health Ministry sources

Monkeypox shots not getting to people who need them the most: US data

The Biden administration said Friday there's enough monkeypox vaccine available now but health officials say the shots aren't getting to some of the people who need the protection the most. About 10% of monkeypox vaccine doses have been given to Black people, even though they account for one-third of US cases, according to the Centres for Disease Control and Prevention. The new numbers come from 17 states and two cities, and represent the most comprehensive details yet on who has been getting the two-dose vaccines. Similar disparities had been reported previously by a few states and cities. Most US monkeypox cases have been in men who have sex with men, but officials have stressed that anyone can catch the virus. Experts offered several possible explanations for the disparity. It may be related to how and where shots are being offered and publicised. It may be that some Black men don't trust doctors and government public health efforts. Or they may be less willing to identify ...

Number of newly reported monkeypox cases decreases worldwide: WHO

Worldwide, 5,907 cases were reported during the week, compared to 7,477 the week before

UK trying out smaller monkeypox vaccine doses amid shortage: Report

Three National Health Service (NHS) sites -- one in Manchester and two in London -- will start administering doses that are five times smaller than the original dose, at 0.1 ml instead of 0.5 ml.